MetroCity Bankshares (MCBS) Competitors $27.62 +0.05 (+0.18%) Closing price 04/1/2025 04:00 PM EasternExtended Trading$27.59 -0.03 (-0.11%) As of 04/1/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MCBS vs. CORZ, FINV, ENVA, BFH, LU, PRK, CLSK, INTR, FBK, and PPBIShould you be buying MetroCity Bankshares stock or one of its competitors? The main competitors of MetroCity Bankshares include Core Scientific (CORZ), FinVolution Group (FINV), Enova International (ENVA), Bread Financial (BFH), Lufax (LU), Park National (PRK), CleanSpark (CLSK), Inter & Co, Inc. (INTR), FB Financial (FBK), and Pacific Premier Bancorp (PPBI). These companies are all part of the "banking" industry. MetroCity Bankshares vs. Core Scientific FinVolution Group Enova International Bread Financial Lufax Park National CleanSpark Inter & Co, Inc. FB Financial Pacific Premier Bancorp Core Scientific (NASDAQ:CORZ) and MetroCity Bankshares (NASDAQ:MCBS) are both finance companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, community ranking, media sentiment, institutional ownership and valuation. Is CORZ or MCBS more profitable? MetroCity Bankshares has a net margin of 27.33% compared to Core Scientific's net margin of 0.00%. MetroCity Bankshares' return on equity of 15.98% beat Core Scientific's return on equity.Company Net Margins Return on Equity Return on Assets Core ScientificN/A N/A N/A MetroCity Bankshares 27.33%15.98%1.79% Do analysts rate CORZ or MCBS? Core Scientific presently has a consensus price target of $19.07, suggesting a potential upside of 138.33%. MetroCity Bankshares has a consensus price target of $36.00, suggesting a potential upside of 30.34%. Given Core Scientific's stronger consensus rating and higher possible upside, equities analysts plainly believe Core Scientific is more favorable than MetroCity Bankshares.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Core Scientific 0 Sell rating(s) 0 Hold rating(s) 15 Buy rating(s) 1 Strong Buy rating(s) 3.06MetroCity Bankshares 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the MarketBeat Community believe in CORZ or MCBS? Core Scientific received 38 more outperform votes than MetroCity Bankshares when rated by MarketBeat users. Likewise, 72.73% of users gave Core Scientific an outperform vote while only 43.90% of users gave MetroCity Bankshares an outperform vote. CompanyUnderperformOutperformCore ScientificOutperform Votes5672.73% Underperform Votes2127.27% MetroCity BanksharesOutperform Votes1843.90% Underperform Votes2356.10% Which has more volatility & risk, CORZ or MCBS? Core Scientific has a beta of 6.83, indicating that its stock price is 583% more volatile than the S&P 500. Comparatively, MetroCity Bankshares has a beta of 0.58, indicating that its stock price is 42% less volatile than the S&P 500. Which has preferable valuation and earnings, CORZ or MCBS? MetroCity Bankshares has lower revenue, but higher earnings than Core Scientific. Core Scientific is trading at a lower price-to-earnings ratio than MetroCity Bankshares, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCore Scientific$510.67M4.61-$1.62B-$5.50-1.45MetroCity Bankshares$139.66M5.02$64.50M$2.5111.00 Does the media favor CORZ or MCBS? In the previous week, Core Scientific had 15 more articles in the media than MetroCity Bankshares. MarketBeat recorded 16 mentions for Core Scientific and 1 mentions for MetroCity Bankshares. MetroCity Bankshares' average media sentiment score of 1.47 beat Core Scientific's score of 0.98 indicating that MetroCity Bankshares is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Core Scientific 10 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive MetroCity Bankshares 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders hold more shares of CORZ or MCBS? 25.3% of MetroCity Bankshares shares are owned by institutional investors. 32.0% of Core Scientific shares are owned by insiders. Comparatively, 27.5% of MetroCity Bankshares shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. SummaryCore Scientific beats MetroCity Bankshares on 10 of the 19 factors compared between the two stocks. Remove Ads Get MetroCity Bankshares News Delivered to You Automatically Sign up to receive the latest news and ratings for MCBS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MCBS vs. The Competition Export to ExcelMetricMetroCity BanksharesState commercial banks IndustryFinance SectorNASDAQ ExchangeMarket Cap$701.63M$3.05B$11.31B$7.86BDividend Yield3.33%3.75%5.40%4.06%P/E Ratio11.0023.0922.6418.67Price / Sales5.023.0825.6087.31Price / Cash14.2110.6317.6134.64Price / Book1.821.172.704.09Net Income$64.50M$372.21M$1.03B$246.93M7 Day PerformanceN/A-1.44%-1.05%-3.16%1 Month Performance-8.78%-5.40%498.37%-6.74%1 Year Performance17.73%17.33%536.41%-0.49% MetroCity Bankshares Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MCBSMetroCity Bankshares4.0722 of 5 stars$27.62+0.2%$36.00+30.3%+15.3%$701.63M$139.66M11.00220Positive NewsCORZCore Scientific3.7985 of 5 stars$9.31+9.4%$19.07+104.8%+126.6%$2.74B$510.67M-1.72200FINVFinVolution Group3.0847 of 5 stars$9.86-1.8%$11.40+15.7%+98.6%$2.66B$13.07B8.504,260Short Interest ↓ENVAEnova International2.9047 of 5 stars$101.88+4.6%$110.14+8.1%+61.9%$2.63B$2.66B13.691,800Analyst UpgradeGap UpBFHBread Financial3.9588 of 5 stars$52.42+4.8%$59.69+13.9%+39.5%$2.57B$3.84B9.446,000LULufax1.2366 of 5 stars$2.97-1.5%$2.98+0.3%-32.4%$2.57B$20.29B-3.8592,400Upcoming EarningsPositive NewsPRKPark National1.9698 of 5 stars$156.82+1.9%$181.75+15.9%+16.1%$2.53B$520.61M16.841,790CLSKCleanSpark3.8205 of 5 stars$8.79+18.1%$21.57+145.4%-59.3%$2.47B$467.49M79.92130INTRInter & Co, Inc.3.4724 of 5 stars$5.61-2.9%$6.78+20.9%-4.2%$2.44B$6.40B14.383,235FBKFB Financial4.4423 of 5 stars$48.55+2.8%$52.60+8.3%+25.4%$2.27B$457.74M19.661,760Analyst UpgradeNews CoveragePPBIPacific Premier Bancorp4.0876 of 5 stars$21.98+1.7%$27.00+22.8%-8.4%$2.12B$567.77M13.401,345Positive News Remove Ads Related Companies and Tools Related Companies Core Scientific Competitors FinVolution Group Competitors Enova International Competitors Bread Financial Competitors Lufax Competitors Park National Competitors CleanSpark Competitors Inter & Co, Inc. Competitors FB Financial Competitors Pacific Premier Bancorp Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MCBS) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MetroCity Bankshares, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MetroCity Bankshares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.